Showing results (61-70 of 292) with videos related to
Sort By:
Pageof 30
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2012
Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymesPhillip Yates, Heather Eng, Li Di, et al.Journal of Medicinal Chemistry|January 9, 2020
Dose Predictions for Drug DesignTristan S Maurer, Dennis Smith, Kevin Beaumont, et al.International Journal of Pharmaceutics|May 7, 2005
Development and application of high throughput plasma stability assay for drug discoveryLi Di, Edward H Kerns, Yan Hong, et al.Journal of Medicinal Chemistry|August 5, 2025
Insights on Volume of Distribution of AcidsDennis Smith, Kevin Beaumont, Tristan S Maurer, et al.Seminars in Cell & Developmental Biology|November 18, 2017
ADARs and editing: The role of A-to-I RNA modification in cancer progressionKajsa Fritzell, Li-Di Xu, Jens Lagergren, et al.Research and Reports in Urology|May 19, 2022
A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific MortalityFabian Söderdahl, Li-Di Xu, Johan Bring, et al.Journal of Medicinal Chemistry|November 8, 2017
Relevance of Half-Life in Drug DesignDennis A Smith, Kevin Beaumont, Tristan S Maurer, et al.Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|August 30, 2011
[Current situation and progression of induced pluripotent stem cells in treating spinal cord injury]Wei Liu, Shao-kun Zhang, Ming Yan, et al.Journal of Pharmaceutical Sciences|February 6, 2017
Human Tissue Distribution of Carbonyl Reductase 1 Using Proteomic Approach With Liquid Chromatography-Tandem Mass SpectrometryWenyi Hua, Hui Zhang, Sangwoo Ryu, et al.Journal of Medicinal Chemistry|October 4, 2018
Clearance in Drug DesignDennis A Smith, Kevin Beaumont, Tristan S Maurer, et al.Pageof 30